PNC Financial Services Group’s TriSalus Life Sciences TLSI Stock Holding History
Bought
Maintained
Sold
Other funds holding TLSI
PNC Financial Services Group's TLSI Position: Q3 2026 in Review
PNC Financial Services Group increased its TriSalus Life Sciences (TLSI) stake by 1,268% in Q3 2026, buying an estimated $8.59K and bringing the position to 1,956 shares worth $8.43K. The position accounts for ﹤0.01% of the portfolio, ranked #4256.
PNC Financial Services Group first reported a position in TLSI in Q3 2025 and has held it in 5 quarters since. 58 funds tracked by Wall St. Rank hold TLSI as of Q3 2026.
- PNC Financial Services Group held 1,956 shares of TriSalus Life Sciences worth $8.43K as of Q3 2026.
- PNC Financial Services Group bought 1,813 TriSalus Life Sciences shares in Q3 2026, an estimated $8.59K.
- TriSalus Life Sciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4256 holding.
- PNC Financial Services Group first reported a position in TriSalus Life Sciences in Q3 2025 and has held it in 5 quarters since.
- 58 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.